| abstract |
THYROSINE KINASE INHIBITORS CONTAINING DIARYLACETYLENE HYDRAZIDE.n The present invention relates to new diarylacetylene hydrazide compounds of formula (I) or their pharmaceutically acceptable salt, such as tyrosine kinase inhibitors, the process for their preparation, and the use of the compounds of general formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of tyrosine kinase-related disorders in warm-blooded animals. |